Alternative Names:

EC 2.7.11.10; I-kappa-B kinase 2; I-kappa-B-kinase beta; IKK-B; IKK-beta; IKK2; IKKB; IkBKB; NFKBIKB; Nuclear factor NF-kappa-B inhibitor kinase beta; kinase IKK-beta;

Application:

WB IP

Reactivity:

Human Mouse

Dilution:

WB 1:500~1:2000 IP 1:50

	Western blot analysis of IKK beta expression in Daudi cell lysate.

Purification:

Affinity-chromatography

Specificity:

IKK beta Antibody detects endogenous levels of IKK beta

Immunogen:

A synthesized peptide derived from human IKK beta

Description:

The NF-κB/Rel transcription factors are present in the cytosol in an inactive state, complexed with the inhibitory IκB proteins (1-3). Most agents that activate NF-κB do so through a common pathway based on phosphorylation-induced, proteasome-mediated degradation of IκB (3-7). The key regulatory step in this pathway involves activation of a high molecular weight IκB kinase (IKK) complex whose catalysis is generally carried out by three tightly associated IKK subunits.

Storage Condition and Buffer:

Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Store at +4°C short term. Store at -20°C long term. Avoid freeze / thaw cycle.